Quintiles Transnational and its owners plan to raise up to $788M in an NYSE IPO that will give the pharmaceuticals testing company a market cap of around $4.9B at the mid-point of a projected price range of $36-40 a share. Quintiles intends to sell 13.8M, while its shareholders, which include TPG and Bain, plan to offer 5.9M shares. Quintiles will trade under the ticker symbol Q. (previous)
Quintiles Transnational and its owners plan to raise up to $788M in an NYSE IPO that will give...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs